Monoclonal Antibody FW6 and Colonic Tumors
Author Information
Author(s): M. Schwonzen, R. Schmits, S.E. Baldus, M. Vierbuchen, F.-G. Hanisch, M. Pfreundschuh, V. Diehl, J. Baral, G. Uhlenbruck
Hypothesis
Can a monoclonal antibody generated against human amniotic fluid mucin identify tumor-associated epitopes in colonic adenocarcinomas?
Conclusion
The monoclonal antibody FW6 strongly identifies a specific epitope in most colonic adenocarcinomas but not in adjacent normal tissues.
Supporting Evidence
- 76% of colonic adenocarcinomas showed strong expression of the FW6 epitope.
- The FW6 epitope was not detected in adjacent histologically normal mucosae.
- MAb FW6 also stained large cell carcinomas of the lung and gastric carcinomas.
Takeaway
Scientists created an antibody that can find certain markers in colon cancer cells, helping to tell them apart from normal cells.
Methodology
The study involved generating a monoclonal antibody from human amniotic fluid and testing its reactivity on various cancer tissues.
Potential Biases
Potential bias in selecting tumor types for analysis could affect the generalizability of the findings.
Limitations
The study primarily focused on a limited number of cancer types and may not generalize to all cancers.
Participant Demographics
The study involved tissues from patients with various types of cancers, but specific demographics were not detailed.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website